Evidence map›Paper›PMID 36877705›Full record

ArticlePloS one2023

A useful tool for the safe diagnosis and control of the two main pandemics of the XXI century: COVID-19 and African Swine Fever disease.

Sandra Barroso-Arévalo, Marta Díaz-Frutos, Aleksandra Kosowska, Marta Pérez-Sancho, Lucas Domínguez, José Manuel Sánchez-Vizcaíno

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Sandra Barroso-ArévaloVISAVET Health Surveillance Center, Complutense University of Madrid, Madrid, Spain.ORCID 0000-0001-6852-2487
Marta Díaz-FrutosVISAVET Health Surveillance Center, Complutense University of Madrid, Madrid, Spain.
Aleksandra KosowskaVISAVET Health Surveillance Center, Complutense University of Madrid, Madrid, Spain.
Marta Pérez-SanchoVISAVET Health Surveillance Center, Complutense University of Madrid, Madrid, Spain.
Lucas DomínguezVISAVET Health Surveillance Center, Complutense University of Madrid, Madrid, Spain.
José Manuel Sánchez-VizcaínoVISAVET Health Surveillance Center, Complutense University of Madrid, Madrid, Spain.
Universidad Complutense de Madrid · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The COVID-19 pandemic and the disease triggered by the African Swine Fever virus are currently two of the main problems regarding public and animal health, respectively. Although vaccination seems to be the ideal tool for controlling these diseases, it has several limitations. Therefore, early detection of the pathogen is critical in order to apply preventive and control measures. Real-time PCR is the main technique used for the detection of both viruses, which requires previous processing of the infectious material. If the potentially infected sample is inactivated at the time of sampling, the diagnosis will be accelerated, impacting positively on the diagnosis and control of the disease. Here, we evaluated the inactivation and preservation properties of a new surfactant liquid for non-invasive and environmental sampling of both viruses. Our results demonstrated that the surfactant liquid effectively inactivates SARS-CoV-2 and African Swine Fever virus in only five minutes, and allows for the preservation of the genetic material for long periods even at high temperatures such as 37°C. Hence, this methodology is a safe and useful tool for recovering SARS-CoV-2 and African Swine Fever virus RNA/DNA from different surfaces and skins, which has significant applied relevance in the surveillance of both diseases.

Indexed as

African Swine FeverAfrican Swine Fever VirusCOVID-19Pulmonary SurfactantsAnimalsCOVID-19 TestingHumansPandemicsSARS-CoV-2Surface-Active AgentsSwinePulmonary SurfactantsSurface-Active Agents

Identifiers

PMID36877705
PMCPMC9987814
OpenAlexW4323294614

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.